Journal
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume 63, Issue -, Pages 165-169Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jpba.2011.12.035
Keywords
Human serum albumin (HSA); Enzyme-linked immunosorbent assay (ELISA); Time-resolved fluorescence energy transfer (TR-FRET); Sensor
Categories
Funding
- National Institutes of Health [GM079891, GM079891-02S1]
Ask authors/readers for more resources
Human serum albumin is the most abundant protein in the body and is an important biomarker used for disease-related diagnosis. Although the traditional enzyme-linked immunosorbent assay (ELISA) approach can precisely measure the concentration of human serum albumin, the multi-step procedure and time-consuming preparations of ELISA limit its diagnostic applications, preventing accurate point-of-care testing, for example. Herein, we report the recent development of an antibody-based albumin sensor that allows for a homogeneous measurement of albumin concentrations in saliva, urine and serum, in which this type of sensor is validated for the first time. The assay only requires simple mixing, and relies on time-resolved (TR) fluorescence resonance energy transfer (FRET) to produce robust, sensitive signals. The whole process, from sample preparation to final read-out, is expected to take less than 1 h and requires only a standard plate-reader, thus making the sensor a convenient and cost-effective tool for albumin analysis. (C) 2012 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available